Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.15) by 6.67 percent. This is unchanged from the same period last year. The company reported quarterly sales of $12.02 million which missed the analyst consensus estimate of $13.48 million by 10.84 percent. This is a 5.90 percent decrease over sales of $12.77 million the same period last year.
Champions Oncology Q3 Adj $(0.16) Misses $(0.15) Estimate, Sales $12.02M Miss $13.48M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.